Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-3-9
pubmed:abstractText
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for peritoneal carcinomitosis (PC) is an aggressive treatment designed to alleviate symptoms and prolong life. It is associated with physical and psychological morbidity. The purpose of this study was to monitor health outcomes related to treatment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1068-9265
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1105-13
pubmed:dateRevised
2007-7-18
pubmed:meshHeading
pubmed-meshheading:17206478-Activities of Daily Living, pubmed-meshheading:17206478-Adenocarcinoma, pubmed-meshheading:17206478-Adult, pubmed-meshheading:17206478-Aged, pubmed-meshheading:17206478-Aged, 80 and over, pubmed-meshheading:17206478-Antibiotics, Antineoplastic, pubmed-meshheading:17206478-Chemotherapy, Cancer, Regional Perfusion, pubmed-meshheading:17206478-Combined Modality Therapy, pubmed-meshheading:17206478-Depression, pubmed-meshheading:17206478-Female, pubmed-meshheading:17206478-Health Status, pubmed-meshheading:17206478-Humans, pubmed-meshheading:17206478-Hyperthermia, Induced, pubmed-meshheading:17206478-Intraoperative Period, pubmed-meshheading:17206478-Male, pubmed-meshheading:17206478-Middle Aged, pubmed-meshheading:17206478-Mitomycin, pubmed-meshheading:17206478-Peritoneal Neoplasms, pubmed-meshheading:17206478-Prospective Studies, pubmed-meshheading:17206478-Quality of Life, pubmed-meshheading:17206478-Questionnaires, pubmed-meshheading:17206478-Survival Rate, pubmed-meshheading:17206478-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.
pubmed:affiliation
Department of Internal Medicine, Section of Hematology and Oncology, Wake Forest University, School of Medicine, Winston-Salem, NC, USA. rmcquell@wfubmc.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't